Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Deborah Birx is Chief Executive Officer at Armata Pharmaceuticals. OQRO lists 3 transactions filed with the SEC under this name, the latest on Jul 14, 2026, each linked to the official Form 4.
Chief Executive Officer
Disclosures on record
3
Companies involved
1
Armata PharmaceuticalsARMP
3 disclosures · Mar 2026 – Jul 2026
Jul 10, 202614Kdisclosed Jul 14
DetailsOfficial recordMar 14, 20264,919disclosed Mar 17
DetailsOfficial recordMar 9, 2026421Kdisclosed Mar 12
DetailsOfficial recordAs of the latest filing on , Deborah Birx reported holding 198,417 shares of Armata Pharmaceuticals (ARMP), worth about $629K at the last close of $3 (Nov 18, 2026).
Armata Pharmaceuticals's proxy statement reports total compensation of $1.25M for Deborah Birx for fiscal year 2025, after $1.84M for 2024. The total is the one in the Summary Compensation Table: it counts stock awards at their value on the grant date, so it is not the cash received. Proxy statement filed Apr 27, 2026
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Armata Pharmaceuticals ARMP | 198,417 | 198K direct | $3 | $629K | Jul 10, 2026 |
Is this Deborah Birx’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Jul 10, 2026, Deborah Birx reported holding 198,417 shares of Armata Pharmaceuticals (ARMP). At the last close of $3 on Nov 18, 2026, that is about $629K. This is the stake disclosed in filings, not a net worth.
No public filing gives Deborah Birx's net worth. What SEC Form 4 shows is the stock stake: 198,417 shares of Armata Pharmaceuticals (ARMP), about $629K at the last close. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.
Armata Pharmaceuticals's proxy statement reports total compensation of $1.25M for Deborah Birx for fiscal year 2025, after $1.84M for 2024. The total is the one in the Summary Compensation Table: it counts stock awards at their value on the grant date, so it is not the cash received.